13F HOLDINGS REPORT
FCPM III SERVICES B.V.
Quarter ended Q1 2024 · Filed May 3, 2024 · Accession 0001802806-24-000028
Total Value
$707.3M
Positions
10
Other Managers
2
Confidential Omitted
No
Holdings (10)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | DYNE THERAPEUTICS INC | DYN | 6,416,793 | $182.2M | 25.75% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 6,635,391 | $156.9M | 22.19% |
| 3 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 5,196,070 | $122.9M | 17.37% |
| 4 | ENGENE HOLDINGS INC | ENGNW | 5,783,752 | $98.0M | 13.86% |
| 5 | ENGENE HOLDINGS INC | ENGNW | 2,894,199 | $49.1M | 6.94% |
| 6 | DYNE THERAPEUTICS INC | DYN | 1,428,571 | $40.6M | 5.73% |
| 7 | REPLIMUNE GROUP INC | REPL | 4,866,449 | $39.8M | 5.62% |
| 8 | ENGENE HOLDINGS INC | ENGNW | 2,403,072 | $12.5M | 1.77% |
| 9 | ACHILLES THERAPEUTICS PLC | 00449L102 | 2,390,050 | $3.0M | 0.42% |
| 10 | ENGENE HOLDINGS INC | ENGNW | 475,076 | $2.5M | 0.35% |